Simon J Harrison

Simon J Harrison

UNVERIFIED PROFILE

Are you Simon J Harrison?   Register this Author

Register author
Simon J Harrison

Simon J Harrison

Publications by authors named "Simon J Harrison"

Are you Simon J Harrison?   Register this Author

59Publications

1262Reads

48Profile Views

.

Blood 2019 Aug 29. Epub 2019 Aug 29.

Division of Cancer Medicine, Peter MacCallum Cancer Centre, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2019000765DOI Listing
August 2019

Physical Activity Preferences for People Living With Multiple Myeloma: A Qualitative Study.

Cancer Nurs 2017 Sep/Oct;40(5):E1-E8

Author Affiliations: Institute of Sport, Exercise and Active Living (ISEAL), Victoria University, Melbourne, Australia (Dr Craike); Austin Health, Heidelberg, Australia (Ms Hose); Faculty of Physical Education and Recreation, University of Alberta, Edmonton, Canada (Dr Courneya); Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, and Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia (Dr Harrison); and Deakin University, Geelong, Australia, Faculty of Health (Dr Livingston).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NCC.0000000000000425DOI Listing
September 2017

Multiple myeloma of the spine.

Neuroradiol J 2017 Jun 20;30(3):259-268. Epub 2017 Apr 20.

5 Department of Cancer Medicine, Peter MacCallum Cancer Centre, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1971400917699426DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480803PMC
June 2017

Epidemiology of bloodstream infections in patients with myeloma receiving current era therapy.

Eur J Haematol 2017 Feb 10;98(2):149-153. Epub 2016 Oct 10.

Department of Infectious Diseases, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12813DOI Listing
February 2017

Infection risk with immunomodulatory and proteasome inhibitor-based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysis.

Eur J Cancer 2016 11 1;67:21-37. Epub 2016 Sep 1.

Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Australia; Department of Medicine, University of Melbourne, Parkville, Australia; Victorian Infectious Diseases Service, Doherty Institute for Infection and Immunity, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.07.025DOI Listing
November 2016

Outcome of the Stryker® Trident 'All-Poly' constraint acetabular insert: a district general hospital experience.

Hip Int 2015 Nov-Dec;25(6):557-62. Epub 2015 Jun 22.

Department of Trauma and Orthopaedics, Huddersfield Royal Infirmary, Huddersfield - UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/hipint.5000263DOI Listing
October 2016

Update and new approaches in the treatment of Castleman disease.

J Blood Med 2016 3;7:145-58. Epub 2016 Aug 3.

Department of Haematology; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/JBM.S60514DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976903PMC
August 2016

Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization.

Expert Rev Anti Infect Ther 2015 31;13(11):1325-36. Epub 2015 Aug 31.

a 1 Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14787210.2015.1083858DOI Listing
July 2016

Antiviral prophylaxis for varicella zoster virus infections in patients with myeloma in the era of novel therapies.

Leuk Lymphoma 2016 07 4;57(7):1719-22. Epub 2016 Jan 4.

a Department of Infectious Diseases , Peter MacCallum Cancer Centre , East Melbourne , Victoria , Australia ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1106538DOI Listing
July 2016

Myeloma of the central nervous system - an ongoing conundrum!

Leuk Lymphoma 2016 07 21;57(7):1505-6. Epub 2016 Mar 21.

c St Vincent's Hospital , Melbourne , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2016.1154961DOI Listing
July 2016

The Perspectives of Haematological Cancer Patients on Tissue Banking.

Oncol Ther 2016 3;4(1):91-102. Epub 2016 May 3.

School of Medicine and Public Health, Priority Research Centre for Health Behaviour, University of Newcastle, Newcastle, NSW Australia ; Hunter Medical Research Institute, Newcastle, NSW Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40487-016-0019-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315074PMC
May 2016

Plasmacytoma of the testis in a patient with relapsed and refractory multiple myeloma: Case report and review of the literature.

Urol Ann 2015 Oct-Dec;7(4):530-3

Department of Surgery, University of Melbourne, Austin Hospital, Melbourne, Australia ; Olivia Newton-John Cancer Research Department, Austin Hospital, Melbourne, Australia ; Department of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0974-7796.164844DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660713PMC
December 2015

Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy.

Br J Haematol 2015 Oct 24;171(1):100-8. Epub 2015 Jun 24.

Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.13532
Publisher Site
http://dx.doi.org/10.1111/bjh.13532DOI Listing
October 2015

Comment on "Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma".

Haematologica 2015 Sep;100(9):e379

Peter MacCallum Cancer Centre, East Melbourne, Australia Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.128470DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800680PMC
September 2015

Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital.

Support Care Cancer 2015 Jul 10;23(7):1901-6. Epub 2014 Dec 10.

Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-014-2550-3DOI Listing
July 2015

Myelosuppressive therapies significantly increase pro-inflammatory cytokines and directly cause bone loss.

J Bone Miner Res 2015 May;30(5):886-97

Stem Cell Regulation Unit, St Vincent's Institute of Medical Research, Fitzroy, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbmr.2415DOI Listing
May 2015

The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefit.

Am J Hematol 2015 May 27;90(5):E86-91. Epub 2015 Feb 27.

Peter MacCallum Cancer Centre, East Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23967DOI Listing
May 2015

Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies.

Haematologica 2015 Jan 10;100(1):e28-31. Epub 2014 Oct 10.

Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne Department of Medicine, University of Melbourne Victorian Infectious Diseases Service, Peter Doherty Institute for Infection and Immunity, Parkville, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.114025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281332PMC
January 2015

The choice of multiple myeloma induction therapy affects the frequency and severity of oral mucositis after melphalan-based autologous stem cell transplantation.

Clin Lymphoma Myeloma Leuk 2014 Aug 15;14(4):291-6. Epub 2014 Feb 15.

The Royal Melbourne Hospital, Victoria, Australia; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; University of Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2014.02.001DOI Listing
August 2014

Myeloma and pregnancy: strange bedfellows?

Leuk Lymphoma 2014 Apr 9;55(4):966-8. Epub 2013 Sep 9.

Department of Haematology, Peter MacCallum Cancer Centre , Melbourne , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.837163DOI Listing
April 2014

Changing treatment paradigms for patients with plasma cell myeloma: impact upon immune determinants of infection.

Blood Rev 2014 Mar 10;28(2):75-86. Epub 2014 Feb 10.

Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2014.01.004DOI Listing
March 2014

A cohort study on the incidence and outcome of pulmonary embolism in trauma and orthopedic patients.

BMC Med 2014 Mar 4;12:39. Epub 2014 Mar 4.

Academic Department of Trauma and Orthopaedics, School of Medicine, University of Leeds, Leeds General Infirmary, Clarendon Wing Level A, Great George Street, LS1 3EX Leeds, West Yorkshire, UK.

View Article

Download full-text PDF

Source
http://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7
Publisher Site
http://dx.doi.org/10.1186/1741-7015-12-39DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996019PMC
March 2014

Low uptake of upfront autologous transplantation for myeloma in a jurisdiction with universal health care coverage: a population-based patterns of care study in Australia.

Clin Lymphoma Myeloma Leuk 2014 Feb 1;14(1):61-7. Epub 2013 Oct 1.

Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia; Cancer Strategy and Development, Department of Health, Melbourne, Victoria, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650130043
Publisher Site
http://dx.doi.org/10.1016/j.clml.2013.09.011DOI Listing
February 2014

Histone deacetylase inhibitors reduce glycoprotein VI expression and platelet responses to collagen related peptide.

Thromb Res 2013 Jun 2;131(6):514-20. Epub 2013 May 2.

Cancer Research Division, The Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne 3002, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2013.02.013DOI Listing
June 2013

Emergence of central nervous system myeloma in the era of novel agents.

Hematol Oncol 2012 Dec 5;30(4):170-4. Epub 2011 Dec 5.

Department of Haematology, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne 3002, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.1021DOI Listing
December 2012

M(yeloma)IXing up T maintenance.

Blood 2012 Jan;119(1):1-2

Peter MacCallum Cancer Centre, University of Melbourne.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-11-388181DOI Listing
January 2012

To validate: is it so simple?

Transfus Apher Sci 2011 Oct 27;45(2):209-11. Epub 2011 Aug 27.

Apheresis Unit, Peter MacCallum Cancer Centre, East Melbourne, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14730502110012
Publisher Site
http://dx.doi.org/10.1016/j.transci.2011.07.004DOI Listing
October 2011

The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy.

Blood 2011 Feb 26;117(5):1605-13. Epub 2010 Oct 26.

Hematology Immunology Translational Research Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-04-278432DOI Listing
February 2011

Clinical studies of histone deacetylase inhibitors.

Clin Cancer Res 2009 Jun 9;15(12):3958-69. Epub 2009 Jun 9.

Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Australia and University of Melbourne, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2785DOI Listing
June 2009

Enumeration of blood dendritic cells in patients with multiple myeloma at presentation and through therapy.

Leuk Lymphoma 2008 Dec;49(12):2272-83

Haematology Service, Peter MacCallum Cancer Centre, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1080/1042819080246472
Publisher Site
http://dx.doi.org/10.1080/10428190802464729DOI Listing
December 2008

Immunotherapy of multiple myeloma: the start of a long and tortuous journey.

Expert Rev Anticancer Ther 2006 Dec;6(12):1769-85

DHMO, Peter MacCallum Cancer Centre and Locked Bag 1, A'becket Street, Melbourne, Victoria 8006, Australia.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14737140.6.12.17
Publisher Site
http://dx.doi.org/10.1586/14737140.6.12.1769DOI Listing
December 2006